Spots Global Cancer Trial Database for Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Official Title: Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies
Study ID: NCT05743426
Study Description
Brief Summary: This prospective, single-institution, observational study explores disease outcomes and toxicities in subjects with gastrointestinal malignancies and sarcoma (bone and soft tissue) who are being treated with standard-of-care therapies including radiotherapy. Recent advances in treatment approaches affected disease outcomes and toxicities. Prospective monitoring of disease outcomes and toxicities using standardized assessments will provide information about recent changes in the standard of care and further refine treatment approaches and prospective clinical trial design.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, United States
Contact Details
Name: Theodore K Yanagihara
Affiliation: Lineberger Comprehensive Cancer Center, The University of North Carolina Chapel Hill
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
